News & Updates
Filter by Specialty:
Add-on favipiravir brightens outlook for hospitalized COVID-19 patients
When used in addition to standard of care, favipiravir leads to faster viral clearance and clinical improvement time among patients hospitalized with COVID-19, although it appears to contribute to an increased risk of hyperuricaemia, according to the results of a meta-analysis
Add-on favipiravir brightens outlook for hospitalized COVID-19 patients
06 May 2022
Newer fixed-dose ICS/LABA combos tied to greater adherence, less exacerbations in asthma
Among fixed-dose combinations of inhaled corticosteroids/long-acting beta-2-adrenergic agonists (ICS/LABA), the newer combinations of fluticasone furoate/vilanterol (FF/VI) and fluticasone propionate/formoterol (FP/FORM) are associated with increased treatment persistence and lead to fewer exacerbations among patients with asthma, as shown in a study.
Newer fixed-dose ICS/LABA combos tied to greater adherence, less exacerbations in asthma
05 May 2022
Prilocaine/lidocaine spray safe, effective in men with premature ejaculation
The eutectic-like mixture of prilocaine/lidocaine spray appears to work well in the treatment of men with various types of premature ejaculation, as reflected by a high treatment adherence, according to data from a real-world study.
Prilocaine/lidocaine spray safe, effective in men with premature ejaculation
05 May 2022
Statins confer some protection against breast cancer recurrence in Asians
Taking a statin after breast cancer surgery appears to reduce the risk of disease recurrence in Asians, especially among those with invasive cancers, as shown in a study from Singapore.
